Darren J. Carroll
President bei ARMO BIOSCIENCES INC
Profil
Darren joined Polaris Partners in 2020 and is a managing partner in our Boston office.
Darren currently represents Polaris on the boards of Noema Pharma, Tessa Therapeutics and August Bioservices.
Prior to joining Polaris, Darren completed a 22-year career with Eli Lilly and Company.
As senior vice president of corporate business development he was responsible for all strategic transactions at Lilly, ranging from venture capital investments and acquisitions, to company formation and divestitures.
Earlier, Darren reorganized and led the company’s venture capital operations and formed Lilly Ventures.
He also founded and led Lilly Asia Ventures.
Darren was the founding CEO of InnoCentive, Inc., the first open-innovation company in the life sciences and now a part of Wazoku.
He also led both corporate and new product development at RealMed, a healthcare transactions and technology company that is now part of Availity.
Darren earned an AB, masters in public administration, and juris doctorate from Syracuse University, where he was a University Scholar, University Fellow, L.E.S.
Fellow, and Lehman Fellow.
Aktive Positionen von Darren J. Carroll
| Unternehmen | Position | Beginn |
|---|---|---|
| ARMO BIOSCIENCES INC | President | 21.06.2018 |
| LOXO ONCOLOGY INC | President | - |
Noema Pharma AG
 Noema Pharma AG BiotechnologyHealth Technology Noema Pharma AG is a biotechnology company, which engages in the development of orphan neurological disorder therapies. It focuses on understanding and meeting patient needs using novel therapies. The company was founded by Luigi Costa and George Garibaldi and is headquartered in Basel, Switzerland. | Director/Board Member | 04.10.2021 |
Ehemalige bekannte Positionen von Darren J. Carroll
| Unternehmen | Position | Ende |
|---|---|---|
| ELI LILLY AND COMPANY | Corporate Officer/Principal | 08.08.2019 |
Polaris Growth Management LLC
 Polaris Growth Management LLC Investment ManagersFinance Polaris Partners is an Independent Venture Capital firm founded in 1996 by Stephen D. Arnold, Jonathan A. Flint and Terrance G. McGuire. Polaris Partners is headquartered in Waltham. | Private Equity Investor | - |
| COLUCID PHARMACEUTICALS INC | President | - |
Ic Holdings Group, Inc.
 Ic Holdings Group, Inc. Internet Software/ServicesTechnology Services IC Holdings Group, Inc.engages in the provision of an online platform, which delivers solutions for research and development organizations. The company was founded by Alpheus Bingham, Darren J. Carroll, Jeff Hensley, Jill A. Panetta, Yi Shi, and Amiel M. Kornel in 2001 and is headquartered in Waltham, MA. | Founder | - |
RealMed Corp.
 RealMed Corp. Regional BanksFinance RealMed Corp. provides health care administration solutions which use Internet to automate health care transactions and information exchange between providers, payers, and patients. Its revenue cycle management is a menu of services extended to clients, both payers and providers, which include claims preparation, management, and payments as well as accounts receivable management. The company was founded in 1995 and is headquartered in Indianapolis, IN. | Corporate Officer/Principal | - |
Ausbildung von Darren J. Carroll
| Syracuse University | Graduate Degree |
| Maxwell School of Syracuse University | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| ELI LILLY AND COMPANY | Health Technology |
| GLOBEIMMUNE, INC. | Health Technology |
| Private Unternehmen | 9 |
|---|---|
RealMed Corp.
RealMed Corp. Regional BanksFinance RealMed Corp. provides health care administration solutions which use Internet to automate health care transactions and information exchange between providers, payers, and patients. Its revenue cycle management is a menu of services extended to clients, both payers and providers, which include claims preparation, management, and payments as well as accounts receivable management. The company was founded in 1995 and is headquartered in Indianapolis, IN. | Finance |
Ic Holdings Group, Inc.
Ic Holdings Group, Inc. Internet Software/ServicesTechnology Services IC Holdings Group, Inc.engages in the provision of an online platform, which delivers solutions for research and development organizations. The company was founded by Alpheus Bingham, Darren J. Carroll, Jeff Hensley, Jill A. Panetta, Yi Shi, and Amiel M. Kornel in 2001 and is headquartered in Waltham, MA. | Technology Services |
CoLucid Pharmaceuticals, Inc.
 CoLucid Pharmaceuticals, Inc. BiotechnologyHealth Technology CoLucid Pharmaceuticals, Inc. engaged in the development of therapeutics for neurological disorders. Its products included Lasmiditan, a neurally acting anti-migraine agent that is designed to delivered efficacy in migraine without the vasoconstrictor activity associated with previous generations of migraine therapies and a Conjugated Stigmines platform that has generated a series of preclinical candidates for the chronic pain, Alzheimer's disease and psychiatric disorders. The company was founded by James F. White and Arthur M. Pappas in 2005 and was headquartered in Cambridge, MA. | Health Technology |
Polaris Growth Management LLC
Polaris Growth Management LLC Investment ManagersFinance Polaris Partners is an Independent Venture Capital firm founded in 1996 by Stephen D. Arnold, Jonathan A. Flint and Terrance G. McGuire. Polaris Partners is headquartered in Waltham. | Finance |
LV Management Group, LLC
 LV Management Group, LLC Investment ManagersFinance Lilly Ventures Management Group LLC (Lilly ventures) is a venture capital firm, a subsidiary of Eli Lilly & Co. founded in 2001 by S.Edward Torres and Ron Laufer. The firm is headquartered in Indianapolis,Indiana. | Finance |
Hydra Biosciences, Inc.
 Hydra Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Hydra Biosciences, Inc. develops pharmaceutical products. It is focused in major therapeutic areas, which include pain, inflammation, renal, anxiety, and pulmonary diseases. The company was founded by Laurie Bartlett Keating, Dean Y. Li, David E. Clapham, and Mark T. Keating in 2001 and is headquartered in Belmont, MA. | Health Technology |
Loxo Oncology, Inc.
 Loxo Oncology, Inc. Pharmaceuticals: MajorHealth Technology Loxo Oncology, Inc. is a biopharmaceutical company, which engages in the development of small molecule therapeutics for the treatment of cancer. It focuses on genetic alterations, targeted therapies, and genetic testing. The company was founded by Joshua H. Bilenker in May 2013 and is headquartered in Stamford, CT. | Health Technology |
ARMO BioSciences, Inc.
 ARMO BioSciences, Inc. Pharmaceuticals: MajorHealth Technology ARMO BioSciences, Inc. develops immunotherapy for the treatment of cancer, cardiovascular diseases, fibrosis, and inflammation. Its lead product candidate is AM0010 (pegilodecaki). The company was founded by Peter Van Vlasselaer, Martin Oft, and John B. Mumm on June 23, 2010 and is headquartered in Redwood, CA. | Health Technology |
Noema Pharma AG
Noema Pharma AG BiotechnologyHealth Technology Noema Pharma AG is a biotechnology company, which engages in the development of orphan neurological disorder therapies. It focuses on understanding and meeting patient needs using novel therapies. The company was founded by Luigi Costa and George Garibaldi and is headquartered in Basel, Switzerland. | Health Technology |
